uric acid has been researched along with Heart Failure, Systolic in 2 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Heart Failure, Systolic: Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Studies have shown that increased levels of serum uric acid (SUA) are associated with atrial fibrillation (AF)." | 7.78 | Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure. ( Cui, HY; Huang, CX; Huang, H; Huang, T; Qin, M; Yu, SB; Zhao, QY, 2012) |
| "Studies have shown that increased levels of serum uric acid (SUA) are associated with atrial fibrillation (AF)." | 3.78 | Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure. ( Cui, HY; Huang, CX; Huang, H; Huang, T; Qin, M; Yu, SB; Zhao, QY, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, AH | 1 |
| Ghali, JK | 1 |
| Neuberg, GW | 1 |
| O'Connor, CM | 1 |
| Carson, PE | 1 |
| Levy, WC | 1 |
| Zhao, QY | 1 |
| Yu, SB | 1 |
| Huang, H | 1 |
| Cui, HY | 1 |
| Qin, M | 1 |
| Huang, T | 1 |
| Huang, CX | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Allopurinol in the Treatment of Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Treated by Either PCI or CABG: Pilot Study[NCT03700645] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-12-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for uric acid and Heart Failure, Systolic
| Article | Year |
|---|---|
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure.
Topics: Aged; Allopurinol; Biomarkers; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Failure, Systolic | 2010 |
1 other study available for uric acid and Heart Failure, Systolic
| Article | Year |
|---|---|
Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure.
Topics: Aged; Atrial Fibrillation; Female; Heart Failure, Systolic; Humans; Male; Middle Aged; Uric Acid | 2012 |